Antibody-neutralizing activity against all urogenital Chlamydia trachomatis serovars in Chlamydia suis-infected pigs.

It is known that neutralizing species-specific or serovar-specific antibodies are produced in response to chlamydial infection in humans and in some animal species. In a previous study, a strong in vitro neutralizing activity to Chlamydia suis in 80% of sera from C. suis-infected pigs had been observed. In view of the close relationship between C. suis and Chlamydia trachomatis, in the present study, the neutralizing activity against D-K C. trachomatis and C. suis purified elementary bodies (EBs) in sera collected from C. trachomatis-infected patients and C. suis-infected pigs was evaluated. A neutralizing activity of 50-70% was observed in the human sera against the homologous serovar and one to five heterologous C. trachomatis serovars. These sera were also able to neutralize C. suis EBs. The pig sera showed a strong neutralizing activity (70-100%) against C. suis EBs and all eight urogenital C. trachomatis serovars. These results suggested the presence of common immunogenic antigens in C. trachomatis and C. suis. Immunoblot analysis, performed to elucidate the target of this neutralizing activity, showed a clear reactivity in human and pig sera against two proteins of 150 and 40 kDa MW, when tested either with C. trachomatis or with C. suis EBs.

[1]  D. Crane,et al.  Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine1 , 2009, The Journal of Immunology.

[2]  S. Magnino,et al.  In vitro detection of neutralising antibodies to Chlamydia suis in pig sera , 2009, Veterinary Record.

[3]  S. Magnino,et al.  Sensitivity of Chlamydia suis to cathelicidin peptides. , 2007, Veterinary microbiology.

[4]  D. Crane,et al.  Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Magnino,et al.  In vitro detection of neutralizing antibodies to Chlamydophila psittaci in pigeon sera with a microneutralization test , 2006 .

[6]  R. Schneider,et al.  Evidence for numerous omp1 alleles of porcine Chlamydia trachomatis and novel chlamydial species obtained by PCR , 1997, Journal of clinical microbiology.

[7]  F. Rumpianesi,et al.  Detection of serum antibodies against Chlamydia pneumoniae by in vitro neutralization and microimmunofluorescence assays. , 1996, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[8]  A. Andersen,et al.  Lung and Nasal Lesions Caused by a Swine Chlamydial Isolate in Gnotobiotic Pigs , 1996, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[9]  M. Lavin,et al.  Some aspects of the immune response of koalas (Phascolarctos cinereus) and in vitro neutralization of Chlamydia psittaci (koala strains). , 1993, FEMS immunology and medical microbiology.

[10]  H. Taylor.  Development of immunity to ocular chlamydial infection. , 1990, The American journal of tropical medicine and hygiene.

[11]  E. Peterson,et al.  Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera , 1990, Infection and immunity.

[12]  H. Fukushi,et al.  Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci , 1988, Journal of clinical microbiology.

[13]  H. Caldwell,et al.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis , 1981, Infection and immunity.

[14]  N. Sugg,et al.  Plaque Reduction Technique for Demonstrating Neutralizing Antibodies for Chlamydia , 1970, Infection and immunity.

[15]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[16]  L. Hanna,et al.  Experimental inclusion conjunctivitis in man. 3. Keratitis and other complications. , 1967, Archives of ophthalmology.

[17]  M. Tarizzo,et al.  Experimental inoculation of thirteen volunteers with agent isolated from inclusion conjunctivitis. , 1967, American journal of ophthalmology.